Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes

Not all with diabetes at heightened cardiovascular risk may benefit from some of these drugs, so how to choose? And through what mechanisms do SGLT2 inhibitors cut CV risk, anyway?Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news